US Patent Issued to Nasus Pharma on July 14 for "Treatment with powdered intranasal epinephrine" (Israeli Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,402, issued on July 14, was assigned to Nasus Pharma Ltd. (Tel Aviv, Israel).

"Treatment with powdered intranasal epinephrine" was invented by Galia Temtsin-Krayz (Ashdod, Israel) and Pavel Kazhdan (Yavne, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is a pharmaceutical composition in dry powder form for intranasal administration, comprising an anti-anaphylactic adrenergic receptor agonist in the form of dry powder for intranasal administration, the composition comprising solid particles of the active agent in combination with at least one functional additive, and solid particles of an inert carrier."

The patent was filed on Marc...